je.st
news
'Hold' rating on Sun Pharma, a resilient business model: Edelweis
2013-11-25 23:55:11| Food - Topix.net
Strong performance across regions: Sun Pharmaceuticals Industries Q2FY14 adjusted profit after tax at R13.6 bn was ahead of estimated Rs 12.9 bn primarily due to strong sales and margins of Taro.
Tags: business
rating
model
hold
Category:Food and Related Products
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||